- Home
- LYEL vs TGTX Comparison
LYEL vs TGTX Comparison
Compare LYEL & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- TGTX
- Stock Information
- Founded
- LYEL 2018
- TGTX 1993
- Country
- LYEL United States
- TGTX United States
- Employees
- LYEL N/A
- TGTX N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- TGTX Biotechnology: Pharmaceutical Preparations
- Sector
- LYEL Health Care
- TGTX Health Care
- Exchange
- LYEL Nasdaq
- TGTX Nasdaq
- Market Cap
- LYEL 207.7M
- TGTX N/A
- IPO Year
- LYEL 2021
- TGTX 1995
- Fundamental
- Price
- LYEL $9.69
- TGTX $36.72
- Analyst Decision
- LYEL Sell
- TGTX Strong Buy
- Analyst Count
- LYEL 2
- TGTX 5
- Target Price
- LYEL $15.00
- TGTX $40.80
- AVG Volume (30 Days)
- LYEL 232.0K
- TGTX 1.7M
- Earning Date
- LYEL 08-06-2025
- TGTX 08-05-2025
- Dividend Yield
- LYEL N/A
- TGTX N/A
- EPS Growth
- LYEL N/A
- TGTX N/A
- EPS
- LYEL N/A
- TGTX 0.24
- Revenue
- LYEL $65,000.00
- TGTX $386,386,000.00
- Revenue This Year
- LYEL N/A
- TGTX $84.81
- Revenue Next Year
- LYEL N/A
- TGTX $38.34
- P/E Ratio
- LYEL N/A
- TGTX $154.20
- Revenue Growth
- LYEL N/A
- TGTX 33.54
- 52 Week Low
- LYEL $7.65
- TGTX $16.65
- 52 Week High
- LYEL $38.40
- TGTX $46.48
- Technical
- Relative Strength Index (RSI)
- LYEL 51.52
- TGTX 50.43
- Support Level
- LYEL $8.46
- TGTX $35.03
- Resistance Level
- LYEL $9.84
- TGTX $38.08
- Average True Range (ATR)
- LYEL 0.86
- TGTX 1.31
- MACD
- LYEL -0.05
- TGTX -0.05
- Stochastic Oscillator
- LYEL 47.00
- TGTX 66.37
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.